Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FTO vs FTD for Prevention of Delayed CINV in Multiple Myeloma Patients Undergoing HSCT
NCT07413809Phase 3Recruiting
- Sponsor
- The Affiliated People’s Hospital of Ningbo University
- Start
- Oct 2025
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olanzapine in chemotherapy-induced nausea and vomiting (CINV), sponsored by The Affiliated People’s Hospital of Ningbo University. Started Oct 2025; status: recruiting.
02
Drugs
olanzapine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT07413809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07413809.